BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP AND Treatment
447 results:

  • 1. Influence of Post-radiation Ocular Surface Disorder on Ocular Surgery: A Case Report and Review of the Literature.
    Gjukaj D; Morina I; Valmaggia C; Ammann D; Todorova MG
    Klin Monbl Augenheilkd; 2024 Apr; 241(4):421-425. PubMed ID: 38653304
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Postpartum Breast Cancer and Survival in Women With germline BRCA Pathogenic Variants.
    Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
    JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Emerging therapeutic strategies for metastatic uveal melanoma: Targeting driver mutations.
    Liu XL; Run-Hua Z; Pan JX; Li ZJ; Yu L; Li YL
    Pigment Cell Melanoma Res; 2024 May; 37(3):411-425. PubMed ID: 38411373
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Predictive and prognostic biomarkers in urological tumours.
    Cimadamore A; Franzese C; Di Loreto C; Blanca A; Lopez-Beltran A; Crestani A; Giannarini G; Tan PH; Carneiro BA; El-Deiry WS; Montironi R; Cheng L
    Pathology; 2024 Mar; 56(2):228-238. PubMed ID: 38199927
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Development and external validation of dual online tools for prognostic assessment in elderly patients with high-grade glioma: a comprehensive study using SEER and Chinese cohorts.
    Zhang H; Jiang X; Ren F; Gu Q; Yao J; Wang X; Zou S; Gan Y; Gu J; Xu Y; Wang Z; Liu S; Wang X; Wei B
    Front Endocrinol (Lausanne); 2023; 14():1307256. PubMed ID: 38075045
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. brca1/2 reversion mutations in a pan-cancer cohort.
    Nakamura K; Hayashi H; Kawano R; Ishikawa M; Aimono E; Mizuno T; Kuroda H; Kojima Y; Niikura N; Kawanishi A; Takeshita K; Suzuki S; Ueno S; Okuwaki K; Sasaki J; Yamaguchi M; Masuda K; Chiyoda T; Yamagami W; Okada C; Nohara S; Tanishima S; Nishihara H
    Cancer Sci; 2024 Feb; 115(2):635-647. PubMed ID: 38041241
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Iridociliary Body Metastasis of Atypical Carcinoid: Case Management with Intravitreal Anti-Vascular Endothelial Growth Factor Injections.
    Zhang Y; Bian AL; Dai RP
    Chin Med Sci J; 2023 Dec; 38(4):305-308. PubMed ID: 37914401
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
    Lim JZ; Crawford AZ; McGhee CNJ
    Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of three-weekly and six-weekly pembrolizumab United Kingdom prescribing practice for advanced and resected melanoma.
    Mehta I; Dayimu A; Kumar S; Boobier C; Oladipo O; Burke D; Olson-Brown A; Yesildag P; Nobes J; Brown S; Booth C; Wheater M; Muller D; Fountain V; Ford L; Board R; McGurk L; Twelves S; Demiris N; Corrie P
    Eur J Cancer; 2023 Nov; 194():113344. PubMed ID: 37804771
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. tumor-infiltrating lymphocyte transfusion in a patient with treatment refractory triple negative breast cancer.
    Jacover A; Zarbiv Y; Tal KH; Klein S; Breuer S; Durst R; Avni B; Grisariu S; Stepensky P; Lotem M; Maimon O; Yablonski-Peretz T
    Cancer Rep (Hoboken); 2023 Dec; 6(12):e1894. PubMed ID: 37750497
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Metastatic extradural melanoma of the lumbar spine in a cat.
    Fert S; River P; Bondonny L; Cauzinille L
    Vet Med Sci; 2023 Nov; 9(6):2393-2398. PubMed ID: 37656442
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Breast cancers arising in subjects with germline brca1 or BRCA2 mutations: Different biological and clinical entities with potentially diverse therapeutic opportunities.
    Zattarin E; Taglialatela I; Lobefaro R; Leporati R; FucĂ  G; Ligorio F; Sposetti C; Provenzano L; Azzollini J; Vingiani A; Ferraris C; Martelli G; Manoukian S; Pruneri G; de Braud F; Vernieri C
    Crit Rev Oncol Hematol; 2023 Oct; 190():104109. PubMed ID: 37643668
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Assembling a Cinnamyl Pharmacophore in the C3-Position of Substituted Isatins via Microwave-Assisted Synthesis: Development of a New Class of Monoamine Oxidase-B Inhibitors for the treatment of Parkinson's Disease.
    Manoharan A; Oh JM; Benny F; Kumar S; Abdelgawad MA; Ghoneim MM; Shaker ME; El-Sherbiny M; Almohaimeed HM; Gahtori P; Kim H; Mathew B
    Molecules; 2023 Aug; 28(16):. PubMed ID: 37630420
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A novel RBBP8(p.E281*) germline mutation is a predisposing mutation in familial hereditary cancer syndrome.
    Yan J; Wu J; Wang Y; Di X; Jiang H; Wen D; Li D; Zhang S
    J Mol Med (Berl); 2023 Oct; 101(10):1255-1265. PubMed ID: 37615686
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Homologous Recombination Deficiency (HRD) in Cutaneous Oncology.
    Akinjiyan FA; Morecroft R; Phillipps J; Adeyelu T; Elliott A; Park SJ; Butt OH; Zhou AY; Ansstas G
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445949
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
    Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Does vitreous haemorrhage and calcification lead to increased risk of enucleation in advanced retinoblastoma?
    He M; Yang L; Jia S; Yang J; Wen X; Fan J; Jia R; Fan X
    Acta Ophthalmol; 2024 May; 102(3):e296-e301. PubMed ID: 37431955
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma Associated.
    Pike S; Peng CC; Neviani P; Berry JL; Xu L
    Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):5. PubMed ID: 37410475
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Misuse of tumor marker levels leads to an insufficient International germ cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
    Majewski M; Paffenholz P; Ruf C; Che Y; Seidel C; Heinzelbecker J; Schmelz HU; Matthies C; Albers P; Bokemeyer C; Heidenreich A; Pichler M; Nestler T;
    Cancer Med; 2023 Aug; 12(16):16829-16836. PubMed ID: 37392170
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms.
    Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F
    Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 23.